A cloud bioreactor allows you to run bioreactor experiments virtually - you design your experiment on a website and it’s run according to your exact specs in a lab. This is a technology that we've custom-built here at Culture Biosciences. By using our cloud bioreactor lab, our clients (bioprocess engineers and scientists) can access more bioreactor capacity without building or expanding their own lab.
Cloud bioreactors enable a few key features for customers:
1-2 years
1-2 months
Over $1 Million in CAPEX.
No CAPEX. No depreciating assets, overhead costs, or need to expand team to manage bioreactors.
50% of scientists’ time running bioreactors.
0% of scientists’ time running bioreactors. 100% spent on experiment design and analysis.
Requires additional equipment installation to track off-gas and mass balances.
Hardware and software to accurately track mass in bioreactor are included.
30% of scientists’ time compiling and reformatting data.
0% of scientist’s time wrangling data. Real-time data visualizations for faster insights.
A year after purchase, still in process of building a high-quality fermentation operation internally.
Collect data 12x sooner than if running bioreactors internally, leading to faster decision-making.
1-2 years
Over $1 Million in CAPEX.
50% of scientists’ time running bioreactors.
Requires additional equipment installation to track off-gas and mass balances.
30% of scientists’ time compiling and reformatting data.
From purchase decision through first full year of use ____.
1-2 months
No CAPEX. No depreciating asset, overhead costs, or need to expand team to manage bioreactors.
0% of scientists’ time running bioreactors. 100% spent on experiment design and analysis.
Hardware and software to accurately track mass in bioreactor are included.
0% scientist’s time wrangling data. Real-time data visualizations for faster insights.
In first year, do 5x the number of runs you could do internally
“Once we learned we could get high-quality data by running experiments in Culture's cloud bioreactor lab instead of doing it ourselves - and we could monitor everything in real time - it didn't make sense to buy our own bioreactor system.”